Latest Stock Split Details
Key information about Shield Therapeutics plc's most recent stock split
Split Date: 2022-12-16
Split Ratio: 1029:1000
Price Before Split: $6.95
Price After Split: $6.75
Developer API
Get STX.L split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/STX.L
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.03 times more shares (a 1029:1000 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Shield Therapeutics plc's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-12-16 | 1029:1000 | No | $6.95 | $6.75 |
| 2021-03-01 | 1029:1000 | No | $40.24 | $39.10 |
About Shield Therapeutics plc
Company overview and industry information
Shield Therapeutics plc (STX.L) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1029-for-1000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - Specialty & Generic
Go to Shield Therapeutics plc Summary